Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity

To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare provider...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Glen, Kovalic, Alex J., Graber, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392413/
https://www.ncbi.nlm.nih.gov/pubmed/32384045
http://dx.doi.org/10.3201/eid2608.201160
_version_ 1783564841979478016
author Huang, Glen
Kovalic, Alex J.
Graber, Christopher J.
author_facet Huang, Glen
Kovalic, Alex J.
Graber, Christopher J.
author_sort Huang, Glen
collection PubMed
description To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy.
format Online
Article
Text
id pubmed-7392413
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-73924132020-08-06 Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity Huang, Glen Kovalic, Alex J. Graber, Christopher J. Emerg Infect Dis Dispatch To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy. Centers for Disease Control and Prevention 2020-08 /pmc/articles/PMC7392413/ /pubmed/32384045 http://dx.doi.org/10.3201/eid2608.201160 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Huang, Glen
Kovalic, Alex J.
Graber, Christopher J.
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
title Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
title_full Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
title_fullStr Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
title_full_unstemmed Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
title_short Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
title_sort prognostic value of leukocytosis and lymphopenia for coronavirus disease severity
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392413/
https://www.ncbi.nlm.nih.gov/pubmed/32384045
http://dx.doi.org/10.3201/eid2608.201160
work_keys_str_mv AT huangglen prognosticvalueofleukocytosisandlymphopeniaforcoronavirusdiseaseseverity
AT kovalicalexj prognosticvalueofleukocytosisandlymphopeniaforcoronavirusdiseaseseverity
AT graberchristopherj prognosticvalueofleukocytosisandlymphopeniaforcoronavirusdiseaseseverity

Ejemplares similares